article thumbnail

Sleep Apnea Prevalence in Cardio-Oncology Patients Similar to Other Risk Factors

HCPLive

and sleep apnea prevalence in cardio-oncology patients was the same or greater than other traditional risk factors. Sleep apnea prevalence in cardiology patients was similar to the rates in patients with heart failure.,

article thumbnail

Long-term Survivors of Childhood Cancer at Higher Risk of Death Following Heart Issues; Threshold for Treating Risk Factors Should be Lower

DAIC

The findings – published this week in the Journal of the American College of Cardiology — could fuel advocacy for a paradigm shift in clinical heart health guidelines to address cardiovascular risk factors at an earlier age in childhood cancer survivors. “We Collaborators on Bottinor’s research include Eric Chow M.D.,

article thumbnail

Study Finds Air Pollution Can Increase Cardiovascular Risk for Cancer Patients

DAIC

The review underscores the critical need to consider environmental factors, especially air pollution, in cardio-oncology risk assessment and patient management,” said Xiaoquan Rao , MD, PhD, senior author of the study and a cardiologist at Tongji Hospital at the Tongji Medical College in Wuhan, China. “By

article thumbnail

Features of trastuzumab-related cardiac dysfunction: deformation analysis outside left ventricular global longitudinal strain

Frontiers in Cardiovascular Medicine

Objectives This study aimed to identify the incidence of early cancer therapy-related cardiac dysfunction (CTRCD) and the behaviours of left and right heart deformations during trastuzumab chemotherapy in low- and moderate-risk patients. Results Twelve (10.9%) patients had asymptomatic CTRCD.

article thumbnail

Burden and prognostic impact of cardiovascular disease in patients with cancer

Heart BMJ

The number of patients at the intersection of cancer and cardiovascular disease (CVD) is increasing, reflecting ageing global populations, rising burden of shared cardiometabolic risk factors, and improved cancer survival. Many cancer treatments carry a risk of cardiotoxicity.

article thumbnail

Cardiotoxicity of adjuvant chemotherapy with trastuzumab: a Japanese claim-based data analysis

Open Heart

Propensity score (PS) was calculated using logistic regression based on age, cardiovascular risk factors, radiotherapy and concomitant anthracyclines (AC). Results We identified 12 060 eligible patients (mean age 50.8±8.56 years) between January 2010 and December 2019. preoperative, 66.0% pre-AC and 86.6% pre-TZ, respectively.